基因改造動物市場：按動物種類、技術、應用、疾病領域、最終用戶和地區分類

基因改造動物市場預計在2026年達到43.8億美元，預計到2033年將達到88.7億美元。預計從2026年到2033年，其複合年成長率將達到10.6%。

全球基因改造動物市場是生物技術和製藥行業的創新領域，涵蓋用於科學研究、藥物開發和治療應用的基因工程動物。基因改造動物透過基因工程技術創造，攜帶外源基因或修飾的內源基因，使研究人員能夠研究人類疾病、測試潛在治療方法並開發新的治療方法。這些動物是理解複雜生物過程、遺傳疾病和疾病機制的重要活體模型，而這些過程和機制在傳統的實驗室環境中是無法複製的。

市場主要包括基因轉殖小鼠、大鼠、兔子、豬和其他專門用於生物醫學研究、藥物測試和學術研究的實驗動物。在個人化醫療需求不斷成長、遺傳疾病日益普遍以及生物技術研究投資不斷增加的推動下，基因改造動物市場正經歷顯著成長。該產業在加速藥物研發進程、縮短新療法上市時間以及透過更精確的臨床前模型來提高臨床試驗成功率方面發揮著至關重要的作用。

市場動態

全球基因改造動物市場受多種強勁因素驅動，這些因素持續推動製藥和生物技術領域的擴張。關鍵成長要素包括對個人化醫療和標靶治療日益成長的需求，而這需要精密的動物模型來了解個別基因變異和治療反應。隨著遺傳疾病、癌症、糖尿病和神經系統疾病的日益普遍，對基因改造動物所能提供的精準疾病模型的需求也日益成長。除了增加對生物技術研發的投資外，政府對基因組研究的資助也為市場成長奠定了堅實的基礎。

基因改造動物在藥物發現和開發過程中的日益普及，使其成為製藥公司不可或缺的工具，顯著縮短了新藥上市的時間並降低了成本。然而，這個市場也面臨許多限制因素，包括嚴格的動物實驗法律法規、圍繞動物基因改造的倫理問題，以及建立和維護基因改造動物族群的高成本。複雜的育種流程、對特殊飼養環境的需求以及對專業技術人員的需求，也為營運帶來了挑戰。

此外，諸如晶片器官技術和電腦建模等替代檢測方法的出現也構成了潛在的競爭威脅。儘管面臨這些挑戰，但仍存在巨大的機遇，包括生物技術研究新興市場的快速擴張、用於培育抗病牲畜的農業應用日益增多，以及基因治療和再生醫學研究等新興治療領域對基因改造動物的需求不斷成長。

本次調查的主要特點

• 本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
• 此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
• 本研究根據以下參數對全球基因改造動物市場的主要參與者進行了分析：公司亮點、產品系列、主要特徵、財務表現和策略。
• 透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
• 這份全球基因改造動物市場報告面向該行業的各類相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
• 透過分析全球基因改造動物市場中使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要

第3章：市場動態、監管與趨勢分析

• 市場動態
• 促進因素
• 抑制因子
• 機會
• 影響分析
• 主要進展
• 監管趨勢
• 產品上市及核准
• PEST分析
• 波特的分析
• 併購情景
• 產業趨勢

第4章 全球基因改造動物市場：依動物類型分類，2021-2033年

• 老鼠
• 鼠
• 斑馬魚
• 豬
• 牛
• 羊
• 山羊
• 雞
• 其他（非人靈長類、兔子）

第5章 全球基因改造動物市場：依技術分類，2021-2033年

• 顯微注射
• 胚胎幹細胞（ESC）注射
• 核移植（克隆技術）
• CRISPR/Cas9 和其他基因編輯技術
• 利用病毒載體的基因改造技術

第6章 全球基因改造動物市場：依應用領域分類，2021-2033年

• 生物醫學研究
• 藥物發現與開發
• 毒理學和安全性測試
• 疾病模型
• 再生醫學
• 異種移植
• 生物製藥生產
• 農業特性的改善

第7章 全球基因改造動物市場：依疾病類別分類，2021-2033年

• 腫瘤學
• 神經病變
• 心血管疾病
• 代謝性疾病
• 免疫性疾病與自體免疫疾病
• 遺傳性和罕見疾病
• 感染疾病

第8章 全球基因改造動物市場：依最終用戶分類，2021-2033年

• 學術研究機構
• 製藥公司
• 生技公司
• 受託研究機構（CRO）
• 農業研究機構
• 政府和監管機構實驗室

第9章 全球基因改造動物市場：依地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲國家
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太國家
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東國家
• 非洲
  • 南非
  • 北非
  • 中非

第10章 競爭格局

• Charles River Laboratories
• Taconic Biosciences
• genOway
• Cyagen Biosciences
• Biocytogen
• Transgenic Inc
• Ozgene
• PolyGene
• Hera BioLabs
• Ingenious Targeting Laboratory
• Applied StemCell
• GemPharmatech
• Harbour BioMed
• Crown Bioscience
• Pharmaron

第11章 分析師建議

• 機會分析
• 分析師意見
• Coherent Opportunity Map

第12章 參考文獻與調查方法

• 參考
• 調查方法
• 關於本公司

Transgenic Animal Market is estimated to be valued at USD 4.38 Bn in 2026 and is expected to reach USD 8.87 Bn by 2033, growing at a compound annual growth rate (CAGR) of 10.6% from 2026 to 2033.

The global transgenic animal market represents a revolutionary segment within biotechnology and pharmaceutical industries, encompassing genetically modified animals engineered for scientific research, drug development, and therapeutic applications. Transgenic animals, created through genetic engineering techniques, carry foreign genes or modified endogenous genes that enable researchers to study human diseases, test potential treatments, and develop novel therapeutic approaches. These animals serve as crucial living models for understanding complex biological processes, genetic disorders, and disease mechanisms that would be impossible to replicate in traditional laboratory settings.

The market primarily includes transgenic mice, rats, rabbits, pigs, and other laboratory animals specifically designed for biomedical research, pharmaceutical testing, and academic studies. With increasing demand for personalized medicine, growing prevalence of genetic disorders, and rising investments in biotechnology research, the transgenic animal market has experienced significant growth. The industry plays a pivotal role in accelerating drug discovery processes, reducing time-to-market for new therapeutics, and enhancing the success rates of clinical trials through more accurate pre-clinical testing models.

Market Dynamics

The global transgenic animal market is driven by several compelling factors that continue to propel its expansion across pharmaceutical and biotechnology sectors. Primary growth drivers include the escalating demand for personalized medicine and targeted therapies, which require sophisticated animal models to understand individual genetic variations and treatment responses. The increasing prevalence of genetic disorders, cancer, diabetes, and neurological diseases has intensified the need for accurate disease models that transgenic animals uniquely provide. Rising investments in biotechnology research and development, coupled with government funding for genomic studies, have created a robust foundation for market growth.

The growing adoption of transgenic animals in drug discovery and development processes significantly reduces the time and cost associated with bringing new medications to market, making them indispensable tools for pharmaceutical companies. However, the market faces notable restraints including stringent regulatory frameworks governing animal research, ethical concerns surrounding genetic modification of animals, and high costs associated with developing and maintaining transgenic animal colonies. Complex breeding procedures, specialized housing requirements, and skilled personnel needs contribute to operational challenges.

Additionally, the emergence of alternative testing methods such as organ-on-chip technologies and computer modeling presents potential competitive threats. Despite these challenges, substantial opportunities exist in emerging markets where biotechnology research is expanding rapidly, increasing applications in agriculture for developing disease-resistant livestock, and growing demand for transgenic animals in emerging therapeutic areas including gene therapy and regenerative medicine research.

Key Features of the Study

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global transgenic animal market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Charles River Laboratories, Taconic Biosciences, genOway, Cyagen Biosciences, Biocytogen, Transgenic Inc, Ozgene, PolyGene, Hera BioLabs, Ingenious Targeting Laboratory, Applied StemCell, GemPharmatech, Harbour BioMed, Crown Bioscience, and Pharmaron
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global transgenic animal market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global transgenic animal market

Market Segmentation

• Animal Type Insights (Revenue, USD Bn, 2021 - 2033)
• Mice
• Rats
• Zebrafish
• Pigs
• Cattle
• Sheep
• Goats
• Chickens
• Others (Non-human primates rabbits)
• Technology Insights (Revenue, USD Bn, 2021 - 2033)
• Microinjection
• Embryonic Stem Cell (ESC) Injection
• Nuclear Transfer (Cloning)
• CRISPR/Cas9 and Other Gene Editing Technologies
• Viral Vector-mediated Transgenesis
• Application Insights (Revenue, USD Bn, 2021 - 2033)
• Biomedical Research
• Drug Discovery and Development
• Toxicology and Safety Testing
• Disease Modeling
• Regenerative Medicine
• Xenotransplantation
• Biopharmaceutical Production
• Agricultural Trait Enhancement
• Disease Area Insights (Revenue, USD Bn, 2021 - 2033)
• Oncology
• Neurological Disorders
• Cardiovascular Diseases
• Metabolic Disorders
• Immunological and Autoimmune Diseases
• Genetic and Rare Diseases
• Infectious Diseases
• End User Insights (Revenue, USD Bn, 2021 - 2033)
• Academic and Research Institutes
• Pharmaceutical Companies
• Biotechnology Companies
• Contract Research Organizations (CROs)
• Agricultural Research Organizations
• Government and Regulatory Laboratories
• Regional Insights (Revenue, USD Bn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
• Charles River Laboratories
• Taconic Biosciences
• genOway
• Cyagen Biosciences
• Biocytogen
• Transgenic Inc
• Ozgene
• PolyGene
• Hera BioLabs
• Ingenious Targeting Laboratory
• Applied StemCell
• GemPharmatech
• Harbour BioMed
• Crown Bioscience
• Pharmaron

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Transgenic Animal Market, By Animal Type
  • Global Transgenic Animal Market, By Technology
  • Global Transgenic Animal Market, By Application
  • Global Transgenic Animal Market, By Disease Area
  • Global Transgenic Animal Market, By End User
  • Global Transgenic Animal Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Transgenic Animal Market, By Animal Type, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Mice
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Rats
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Zebrafish
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Pigs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Cattle
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Sheep
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Goats
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Chickens
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Others (Non-human primates rabbits)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global Transgenic Animal Market, By Technology, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Microinjection
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Embryonic Stem Cell (ESC) Injection
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Nuclear Transfer (Cloning)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• CRISPR/Cas9 and Other Gene Editing Technologies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Viral Vector-mediated Transgenesis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Transgenic Animal Market, By Application, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Biomedical Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Drug Discovery and Development
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Toxicology and Safety Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Disease Modeling
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Regenerative Medicine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Xenotransplantation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Biopharmaceutical Production
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Agricultural Trait Enhancement
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Transgenic Animal Market, By Disease Area, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Neurological Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Cardiovascular Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Metabolic Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Immunological and Autoimmune Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Genetic and Rare Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Infectious Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Transgenic Animal Market, By End User, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Academic and Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Pharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Contract Research Organizations (CROs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Agricultural Research Organizations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Government and Regulatory Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

9. Global Transgenic Animal Market, By Region, 2021 - 2033, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Disease Area, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Disease Area, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Disease Area, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Disease Area, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Disease Area, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Disease Area, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

10. Competitive Landscape

• Charles River Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Taconic Biosciences
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• genOway
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cyagen Biosciences
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Biocytogen
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Transgenic Inc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ozgene
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• PolyGene
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hera BioLabs
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ingenious Targeting Laboratory
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Applied StemCell
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GemPharmatech
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Harbour BioMed
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Crown Bioscience
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pharmaron
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us